Routine

Hirsutism

hirsutism · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Excess terminal hair in a male pattern in women, usually from androgen excess or increased follicular sensitivity. Most cases are PCOS; the priority is excluding rare sinister androgen sources.

Red flags

  • Rapid onset or progression over months
  • Signs of virilisation (clitoromegaly, voice change, male-pattern balding)
  • Testosterone markedly elevated (tumour threshold)
  • Features of Cushing syndrome
  • Palpable pelvic/abdominal mass

Assessment

Differential diagnosis

  • Polycystic ovary syndrome
  • Idiopathic hirsutism
  • Non-classic congenital adrenal hyperplasia
  • Androgen-secreting ovarian/adrenal tumour
  • Cushing syndrome
  • Drug-induced hypertrichosis

Investigations

  • Total and free testosterone
  • DHEAS and 17-hydroxyprogesterone
  • SHBG, LH/FSH and prolactin
  • Pelvic ultrasound
  • 1 mg dexamethasone suppression test if Cushing suspected

Management

  • Quantify severity (e.g. Ferriman-Gallwey) and assess rate of onset
  • Screen for red flags of tumour: rapid onset, virilisation, very high androgens
  • Measure morning testosterone and relevant androgens
  • Exclude non-classic CAH with 17-hydroxyprogesterone and Cushing if clinically suggested
  • Start cosmetic/mechanical measures and discuss realistic timelines (3-6 months)
  • Use combined oral contraceptive as first-line pharmacotherapy
  • Add an antiandrogen if inadequate after 6 months (with reliable contraception)
  • Offer topical eflornithine for facial hair
  • Investigate urgently if androgen-secreting tumour is suspected

Drugs & doses

Combined oral contraceptive (ethinylestradiol with drospirenone/cyproterone) once daily
Spironolactone 50-100 mg PO twice daily
Finasteride 5 mg PO once daily (with contraception) or cyproterone acetate
Eflornithine 11.5% cream topically twice daily for facial hair

Disposition

Manage benign cases in primary care/gynaecology; refer suspected tumour or Cushing to endocrinology urgently for localisation and treatment.

Complications & pitfalls

  • Psychological distress and reduced quality of life
  • Missed androgen-secreting tumour
  • Teratogenicity of antiandrogens without contraception
  • Metabolic consequences of underlying PCOS

Exam pearls

  • Rapid virilising hirsutism with high androgens signals a tumour until proven otherwise
  • Combined oral contraceptive plus antiandrogen is the mainstay for benign cases
  • Hair-growth cycles mean any treatment needs at least 6 months to judge
  • Always pair antiandrogens with reliable contraception

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.